We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+17.55%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$141B
AUM Growth
+$28.7B
Cap. Flow
+$7.51B
Cap. Flow %
5.32%
Top 10 Hldgs %
12.18%
Holding
4,838
New
647
Increased
1,556
Reduced
1,611
Closed
532

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.2B
2
NVDA icon
NVIDIA
NVDA
+$1.02B
3
TMUS icon
T-Mobile US
TMUS
+$911M
4
NFLX icon
Netflix
NFLX
+$699M
5
MU icon
Micron Technology
MU
+$672M

Top Sells

Rank Stock Value
1
GEV icon
GE Vernova
GEV
+$768M
2
HOOD icon
Robinhood
HOOD
+$643M
3
SCHW
Charles Schwab
SCHW
+$534M
4
MSFT icon
Microsoft
MSFT
+$493M
5
INTU icon
Intuit
INTU
+$472M

Sector Composition

Rank Sector Weight
1 Technology 16.33%
2 Healthcare 8.66%
3 Consumer Discretionary 8.33%
4 Financials 6.44%
5 Industrials 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYV icon
851
PUT
Live Nation Entertainment
LYV
$43B
$24.6M 0.02%
162,500
-31,100
-16% -$4.28M
PKG icon
852
Packaging Corp of America
PKG
$22.2B
$24.5M 0.02%
129,853
+53,260
+70% +$10.1M
TPR icon
853
PUT
Tapestry
TPR
$26.4B
$24.4M 0.02%
278,300
-378,000
-58% -$28.6M
BURL icon
854
Burlington
BURL
$20.8B
$24.4M 0.02%
104,847
+21,173
+25% +$5.03M
HCA icon
855
CALL
HCA Healthcare
HCA
$92.9B
$24.3M 0.02%
63,400
+3,100
+5% +$1.12M
RVMD icon
856
Revolution Medicines
RVMD
$45.3B
$24.3M 0.02%
+660,132
New +$25.4M
MIDD icon
857
Middleby
MIDD
$5.21B
$24.2M 0.02%
168,377
-22,865
-12% -$3.22M
KNSL icon
858
Kinsale Capital Group
KNSL
$9.01B
$24.2M 0.02%
49,962
-14,875
-23% -$6.94M
TMO icon
859
PUT
Thermo Fisher Scientific
TMO
$232B
$24.2M 0.02%
59,600
+55,000
+1,196% +$23M
COOP
860
DELISTED
Mr. Cooper
COOP
$24.2M 0.02%
161,863
+137,212
+557% +$17.6M
TECK icon
861
Teck Resources
TECK
$34.4B
$24.1M 0.02%
596,575
-6,315,804
-91% -$228M
TSCO icon
862
Tractor Supply
TSCO
$18.7B
$24.1M 0.02%
+456,622
New +$23.4M
BMY icon
863
Bristol-Myers Squibb
BMY
$137B
$24M 0.02%
518,222
-240,348
-32% -$11.8M
MYGN icon
864
Myriad Genetics
MYGN
$292M
$24M 0.02%
4,511,497
+1,988,879
+79% +$11.7M
NTR icon
865
PUT
Nutrien
NTR
$35.5B
$23.9M 0.02%
410,000
-56,000
-12% -$3.16M
OPTU
866
Optimum Communications Inc
OPTU
$328M
$23.8M 0.02%
11,130,938
-83,039
-0.7% -$195K
MOG.A icon
867
Moog Inc Class A
MOG.A
$12B
$23.8M 0.02%
131,598
+58,953
+81% +$10.3M
TJX icon
868
CALL
TJX Companies
TJX
$155B
$23.7M 0.02%
192,000
+73,900
+63% +$9.37M
TU icon
869
PUT
Telus
TU
$15.5B
$23.7M 0.02%
1,475,000
+800,000
+119% +$12.4M
EVH icon
870
Evolent Health
EVH
$534M
$23.7M 0.02%
2,104,373
+225,373
+12% +$2.07M
CM icon
871
Canadian Imperial Bank of Commerce
CM
$105B
$23.6M 0.02%
332,154
+259,271
+356% +$16.7M
DVN icon
872
CALL
Devon Energy
DVN
$53.1B
$23.6M 0.02%
741,400
+243,400
+49% +$7.75M
ALKS icon
873
Alkermes
ALKS
$8.2B
$23.5M 0.02%
820,096
+351,615
+75% +$10.5M
WFC icon
874
PUT
Wells Fargo
WFC
$256B
$23.4M 0.02%
292,600
-329,100
-53% -$23.7M
EL icon
875
Estee Lauder
EL
$37.7B
$23.4M 0.02%
289,512
-283,214
-49% -$18.2M

Similar funds

David Shaw's Q2 2025 Portfolio in Review

As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.

  • David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
  • David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
  • David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
  • David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
  • David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
  • David Shaw opened 647 new positions and closed 532 in Q2 2025.
  • David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.

Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.